Hormone Therapy for Locally Advanced Prostate Cancer
- 1 August 2002
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- RACE AND CAUSE SPECIFIC SURVIVAL WITH PROSTATE CANCER: INFLUENCE OF CLINICAL STAGE, GLEASON SCORE, AGE AND TREATMENTJournal of Urology, 2000
- Early results of a prospective study of hormone therapy for patients with locally advanced prostate carcinomaCancer, 1998
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997
- Co-Morbidities and Survival of Men with Localized Prostate Cancer Treated with Surgery or Radiation TherapyJournal of Urology, 1996
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995
- The role of neoadjuvant hormonal manipulation in localized prostatic cancerCancer, 1993
- Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)New England Journal of Medicine, 1989
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancerCancer, 1981